Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    75.00 (1.38%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Trading Update

7 Dec 2022 07:00

RNS Number : 8268I
Camellia PLC
07 December 2022
 

7 December 2022

Camellia Plc

 

(the "Company" or the "Group")

 

Trading update

 

Further to the trading announcement on 22 November there has been no change to our expectations for underlying profit before tax for the Group for 2022, with the exception of the trading for BF&M Limited (BF&M) which announced Q3 results yesterday which are significantly below our expectations.

BF&M reported a shareholders' net loss of Bermuda$13.4 million for the nine months ended 30 September 2022, as compared to shareholders' net income for the comparative period in 2021 of Bermuda$19.5 million. Net income from operations after excluding the negative fair value movements in investments was Bermuda$9.3 million versus Bermuda$17.8 million in the first nine months of 2021. Despite the economic headwinds and investment market volatility that continue to impact BF&M results, BF&M's underlying business is trending favourably with Property and Casualty benefiting from a strong rate environment and minimal exposure to Hurricanes Fiona and Ian. Group Life results were strong while Group Health claims remain elevated over pre-pandemic levels. The Pension and Annuity businesses remains well-positioned to optimise opportunities as the markets settle.

Equity attributable to BF&M's shareholders at 30 September 2022 was $294.0 million.

Excluding any financial results for BF&M, the Company believes that the adjusted profit before tax* for the Group will be approximately 50 - 55% below that of last year. In light of BF&M's Q3 results, it is likely that adjusted profit before tax* for the Group for the year ended 31 December 2022 will be lower than announced on 22 November 2022. However as a consequence of the impact of the volatility of equity and bond markets on BF&M's results, it is not possible for Camellia to forecast the likely full year outcome for BF&M with any certainty.

 

* adjusted profit before tax seeks to present an indication of performance which is not impacted by exceptional items or items considered non-operational in nature and for example it excludes impairment charges, gains/losses on disposal of assets and restructuring costs.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMGZGVZGZZZ
Date   Source Headline
19th Jun 20134:25 pmRNSTransaction in Own Shares
18th Jun 20134:32 pmRNSTransaction in Own Shares
17th Jun 20134:39 pmRNSTransaction in Own Shares
14th Jun 20135:16 pmRNSNotification of Major Interest in Shares
14th Jun 20134:33 pmRNSTransaction in Own Shares
14th Jun 20131:22 pmRNSNotification of Major Interest in Shares
12th Jun 20135:22 pmRNSTransaction in Own Shares
11th Jun 20134:28 pmRNSTransaction in Own Shares - Replacement
11th Jun 201310:45 amRNSTransaction in Own Shares
7th Jun 201310:21 amRNSResult of AGM
7th Jun 201310:12 amRNSRe Joint Venture
6th Jun 201312:30 pmRNSAGM Statement
28th Mar 20137:00 amRNSInterim Management Statement
7th Mar 201312:58 pmRNSDirectorate Change
20th Feb 20132:10 pmRNSNotification of Major Interest in Shares
5th Feb 20133:07 pmRNSNotification of Major Interest in Shares
4th Feb 20132:30 pmRNSNotification of Major Interest in Shares
8th Jan 20131:46 pmRNSDirectorate Change
3rd Jan 201311:16 amRNSDirector/PDMR Shareholding
26th Oct 20123:09 pmRNSRevised Interim Management Statement
26th Oct 20127:00 amRNSInterim Management Statement
3rd Sep 20124:47 pmRNSHalf Yearly Report
30th Aug 20127:00 amRNSHalf Yearly Report
8th Jun 201212:13 pmRNSResult of AGM
7th Jun 201212:17 pmRNSAGM Statement
1st Jun 20129:48 amRNSAnnual Information Update
3rd May 201211:21 amRNSAnnual Report 2011, notice of meeting, proxy form
26th Apr 201212:30 pmRNSFinal Results
30th Mar 20127:00 amRNSInterim Management Statement
26th Oct 20117:00 amRNSInterim Management Statement
8th Sep 201112:44 pmRNSCompany Secretary Change
5th Sep 201111:15 amRNSHalf Yearly Report
25th Aug 201112:00 pmRNSHalf Yearly Report
10th Jun 20112:00 pmRNSResult of AGM
9th Jun 201112:24 pmRNSAGM Statement
2nd Jun 20114:25 pmRNSAnnual Information Update
11th May 20113:27 pmRNSAnnual Report 2010, notice of meeting, proxy form
5th May 20111:12 pmRNSDisposal
28th Apr 201112:47 pmRNSAnnual Financial Report
30th Mar 201112:06 pmRNSInterim Management Statement
11th Jan 20114:35 pmRNSPrice Monitoring Extension
27th Oct 20103:16 pmRNSInterim Management Statement
7th Oct 201010:40 amRNSDisposal
8th Sep 20101:42 pmRNSDisposal
3rd Sep 20103:57 pmRNSDoc re. Interim Report 2010
26th Aug 20109:58 amRNSHalf Yearly Report
7th Jun 201010:46 amRNSResult of AGM
3rd Jun 201012:33 pmRNSAGM Statement
2nd Jun 201010:22 amRNSAnnual Information Update
6th May 20104:06 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.